direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Page Content

2019 [1] | 2018 [2] | 2017 [3] | 2016 [4] | 2015 [5] | 2014 [6] | 2013 [7] | 2012 [8] | 2011 [9] | 2010 [10] | 2009 [11] | 2008 [12] | 2007 [13] | 2006 [14] | 2005 [15] | 2004 [16] | 2003 [17] | 2002 [18]

Lectures 2014

Lupe [19]
Lupe [20]

Diagnosis Related Groups in Europe: Adaptations and trends [21]
Diagnosis Related Groups en Europe: Adaptations et tendances [22]
W. Quentin
Genf 26.11.2014

“Living up to Improved Performance” - The role of international projects [23]
Britta Zander
Eupha 22.11.2014

Lupe [24]

Provision of health services: Trends and patterns in Europe (EU 28 + Iceland, Norway and Switzerland) [25]
W. Quentin, J. Cylus, A. Geissler, A. Maresso, S. Merkur, G. Pastorino, A. Sagan
Glasgow 21.11.2014

Lupe [26]

Hospital payment and Diagnosis - Related Groups in Germany - Boone or Bane? [27]
Alexander Geissler, Dr.
Dubrovnik 14.11.2014

Lupe [28]

DRGs: Are hospitals paid for what they do – or do they do for what they are paid? And why patients should care about it [29]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Doha 21.10.2014

Lupe [30]

Medical devices: a taxonomy suitable for HTA [31]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014

Lupe [32]

Medical devices: differences vs. other technologies, especially pharmaceuticals [33]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warsaw, 26.09.2014

Lupe [34]

Inequalities in Health and Health Care [35]
Martin Siegel, Dr.
Dresden 22.09.2014

Lupe [36]

Exploring barriers and dilemmas for the adoption of cost containment strategies in the economic, institutional and political environment [37]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 17.09.2014

Lupe [38]

The German health system: basics and some comparisons with other countries [39]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014

Lupe [40]

From a conservative to a liberal welfare state: decomposing changes in income-related health inequalities in Germany, 1994-2011 [41]
Martin Siegel, Dr.
Dublin 16.07.2014

Lupe [42]

Towards a taxonomy of medical devices in the logic of HTA and economic evaluations rather than marketing authorization [43]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 15.07.2014

A taxonomy of medical devices in the logic of HTA [44]
Dimitra Panteli
Washington 16.06.2014

Equity considerations among HTA agencies –current practice and ways forward [45]
Dimitra Panteli
Washington 16.06.2014

The role of dissemination bias in pharmaceutical coverage decisions: an analysis of practices in European countries [46]
Dimitra Panteli
Washington 16.06.2014

The process of evidence-based decision-making for the reimbursement and pricing of pharmaceuticals in Europe: mapping approaches in 36 countries [47]
Dimitra Panteli
Washington 16.06.2014

Lupe [48]

Intoduction to the healthcare ecosystem and cost factors [49]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 05.05.2014

Lupe [50]

The Health Systems and Policy Monitor (HSPM) [51]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 29.04.2014

Lupe [52]

The European Observatory on Health Systems and Policies [53]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 28.04.2014

Lupe [54]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (II) [55]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [56]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (I) [57]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [58]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview [59]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 14.04.2014

Lupe [60]

Health care reform and pharmaceutical policies in Germany [61]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [62]

Addressing emerging patient needs:from free choice to integrated care [63]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brussels 21.03.2014

Lupe [64]

Hospital payment and DRGs in Germany: The G-DRG system [65]
Wilm Quentin, Dr. med MSc HPPF
Warsaw 18.03.2014

Lupe [66]

The effect of continuity of ambulatory care on hospitalizations in patients with heart failure [67]
Verena Vogt
Munich 17.03.2014

Lupe [68]

The Latvian Health System [69]
Uldis Mittenbergs & Wilm Quentin
Brussels 07.03.2014

Lupe [70]

Regulation and governance of providers (especially hospitals) [71]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [72]

DRGs in Europe: towards transparency, efficiency, and quality of hospital care? [73]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [74]

Implementing competitive UHI: benefit basket, pooling, risk-related allocation and other important considerations [75]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 23.01.2014

Lupe [76]

The financing function: Raising, pooling and allocating resources [77]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [78]

Differences in health care structure and incentives – do they worsen or reduce health inequalities? (… and a framework to examine access to health care …) [79]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [80]

Health system reforms in times of crisis: EU countries [81]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

------ Links: ------

Zusatzinformationen / Extras

Quick Access:

Schnellnavigation zur Seite über Nummerneingabe

Copyright TU Berlin 2008